期刊文献+

Crystal Type Iof Azilsartan Polymorphs: Preparation and Analysis

Crystal Type Iof Azilsartan Polymorphs: Preparation and Analysis
下载PDF
导出
摘要 Azilsartan (2-ethoxy-1-([2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl)-1H-benzimidazole-7-carboxylic acid) is a new angiotensin II receptor antagonist used in the treatment of hypertension. This paper describes the preparation of type I crystal and its single crystal diffraction data, the comparison of the powder diffraction data for both type I and II crystals as well as their stability and solubility in methanol. Azilsartan (2-ethoxy-1-([2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl)-1H-benzimidazole-7-carboxylic acid) is a new angiotensin II receptor antagonist used in the treatment of hypertension. This paper describes the preparation of type I crystal and its single crystal diffraction data, the comparison of the powder diffraction data for both type I and II crystals as well as their stability and solubility in methanol.
作者 Yuhua Ge Tingting Li Jingjing Cheng Yuhua Ge;Tingting Li;Jingjing Cheng(School of Chemistry and Chemical Engineering, Southeast University, Nanjing, China)
出处 《Journal of Crystallization Process and Technology》 2016年第1期1-10,共10页 结晶过程及技术期刊(英文)
关键词 Azilsartan Single Crystal Diffraction Powder Diffraction SOLUBILITY STABILITY Azilsartan Single Crystal Diffraction Powder Diffraction Solubility Stability
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部